Primary Ovarian Insufficiency Consequence of Autoimmune Diseases: a Bidirectional Two-sample Mendelian Randomization Study

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2024 Dec 24

PMID 39717103

Authors

Yongming Du

Yichao Hu

Yuehua Sheng

Tianhong Zhu

Shenping Liu

Huiqing Ding

Yutao Guan

Affiliations

Soon will be listed here.

Abstract

Background: Observational studies suggest the risk of primary ovarian insufficiency (POI) is increased in autoimmune disorders (AIDs), but it is unclear whether there is a causal relationship. Therefore, we aimed to investigate the bidirectional causality between 20 AIDs and POI using Mendelian randomization (MR) analysis.

Methods: A bidirectional two-sample MR investigation was designed by using publicly accessible summary-level data from genome-wide association studies (GWAS). The inverse variance weighted (IVW) method was performed as the main analysis, supplemented by several sensitivity analyses. Cochran Q test was used to evaluate SNP estimate heterogeneity. MR-Egger and MR-PRESSO methods were utilized to detect horizontal pleiotropy.

Results: The MR analyses revealed that genetically determined coeliac disease (CeD) (OR = 1.124, 95% CI 1.033-1.224, P = 0.007), vitiligo (OR = 1.092, 95% CI 1.003-1.188; P = 0.042), systemic lupus erythematosus (SLE) (OR = 1.122, 95% CI 1.030-1.223, P = 0.008), and selective immunoglobulin A deficiency (SIgAD) (OR = 0.866, 95% CI: 0.776-0.967, P = 0.011) exhibited significant causal relationships with POI. We also found suggestive evidence of positive effect of Addison's disease (AD) towards POI (OR = 1.076, 95% CI 1.002-1.154, P = 0.043).

Conclusion: This comprehensive MR analysis indicated that SLE, CeD, vitiligo, and AD caused an increased risk of POI, SIgAD was associated with a decreased risk of POI. These insights carry profound clinical implications, particularly emphasizing the early intervention for women with AIDs/POI who wish to preserve their reproductive potential or plan for future pregnancies.

References

Zhu D, Chung H, Dobson A, Pandeya N, Giles G, Bruinsma F . Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data. Lancet Public Health. 2019; 4(11):e553-e564. PMC: 7118366. DOI: 10.1016/S2468-2667(19)30155-0. View

Luborsky J, Meyer P, Sowers M, Gold E, Santoro N . Premature menopause in a multi-ethnic population study of the menopause transition. Hum Reprod. 2003; 18(1):199-206. DOI: 10.1093/humrep/deg005. View

Magen E, Masalha A, Zueva E, Vardy D . Possible Autoimmune Primary Ovarian Insufficiency in Patients with Selective IgA Deficiency. Isr Med Assoc J. 2018; 20(3):192-193. View

Sakaue S, Kanai M, Tanigawa Y, Karjalainen J, Kurki M, Koshiba S . A cross-population atlas of genetic associations for 220 human phenotypes. Nat Genet. 2021; 53(10):1415-1424. DOI: 10.1038/s41588-021-00931-x. View

Jiao X, Zhang H, Ke H, Zhang J, Cheng L, Liu Y . Premature Ovarian Insufficiency: Phenotypic Characterization Within Different Etiologies. J Clin Endocrinol Metab. 2017; 102(7):2281-2290. DOI: 10.1210/jc.2016-3960. View

Taylor K, Wong Q, Levine D, McHugh C, Laurie C, Doheny K . Genome-Wide Association Analysis Reveals Genetic Heterogeneity of Sjögren's Syndrome According to Ancestry. Arthritis Rheumatol. 2017; 69(6):1294-1305. PMC: 5449251. DOI: 10.1002/art.40040. View

Polyzos N, Sakkas E, Vaiarelli A, Poppe K, Camus M, Tournaye H . Thyroid autoimmunity, hypothyroidism and ovarian reserve: a cross-sectional study of 5000 women based on age-specific AMH values. Hum Reprod. 2015; 30(7):1690-6. DOI: 10.1093/humrep/dev089. View

Bensing S, Giordano R, Falorni A . Fertility and pregnancy in women with primary adrenal insufficiency. Endocrine. 2020; 70(2):211-217. DOI: 10.1007/s12020-020-02343-z. View

Silva C, Yamakami L, Aikawa N, Araujo D, Carvalho J, Bonfa E . Autoimmune primary ovarian insufficiency. Autoimmun Rev. 2014; 13(4-5):427-30. DOI: 10.1016/j.autrev.2014.01.003. View

10.

Li X, Li P, Liu Y, Yang H, He L, Fang Y . Health-related quality-of-life among patients with premature ovarian insufficiency: a systematic review and meta-analysis. Qual Life Res. 2019; 29(1):19-36. PMC: 6962283. DOI: 10.1007/s11136-019-02326-2. View

11.

Comba C, Comba A, Yilmaz H, Erdogan S, Demir O . Celiac disease does not influence markers of ovarian reserve in adolescent girls. Arch Gynecol Obstet. 2020; 302(5):1263-1269. DOI: 10.1007/s00404-020-05666-4. View

12.

Webber L, Davies M, Anderson R, Bartlett J, Braat D, Cartwright B . ESHRE Guideline: management of women with premature ovarian insufficiency. Hum Reprod. 2016; 31(5):926-37. DOI: 10.1093/humrep/dew027. View

13.

Mishra S, Chung H, Waller M, Dobson A, Greenwood D, Cade J . Association Between Reproductive Life Span and Incident Nonfatal Cardiovascular Disease: A Pooled Analysis of Individual Patient Data From 12 Studies. JAMA Cardiol. 2020; 5(12):1410-1418. PMC: 7495334. DOI: 10.1001/jamacardio.2020.4105. View

14.

Vogt E, Breivik L, Royrvik E, Grytaas M, Husebye E, Oksnes M . Primary Ovarian Insufficiency in Women With Addison's Disease. J Clin Endocrinol Metab. 2021; 106(7):e2656-e2663. PMC: 8208662. DOI: 10.1210/clinem/dgab140. View

15.

Unal O, Tuten N . Evaluation of ovarian reserves in women suffering from an autoimmune disease vitiligo. Eur Rev Med Pharmacol Sci. 2023; 27(10):4608-4613. DOI: 10.26355/eurrev_202305_32468. View

16.

Vabre P, Gatimel N, Moreau J, Gayrard V, Picard-Hagen N, Parinaud J . Environmental pollutants, a possible etiology for premature ovarian insufficiency: a narrative review of animal and human data. Environ Health. 2017; 16(1):37. PMC: 5384040. DOI: 10.1186/s12940-017-0242-4. View

17.

Reato G, Morlin L, Chen S, Furmaniak J, Rees Smith B, Masiero S . Premature ovarian failure in patients with autoimmune Addison's disease: clinical, genetic, and immunological evaluation. J Clin Endocrinol Metab. 2011; 96(8):E1255-61. DOI: 10.1210/jc.2011-0414. View

18.

. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril. 2020; 114(6):1151-1157. DOI: 10.1016/j.fertnstert.2020.09.134. View

19.

Sanderson E . Multivariable Mendelian Randomization and Mediation. Cold Spring Harb Perspect Med. 2020; 11(2). PMC: 7849347. DOI: 10.1101/cshperspect.a038984. View

20.

Cordell H, Fryett J, Ueno K, Darlay R, Aiba Y, Hitomi Y . An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs. J Hepatol. 2021; 75(3):572-581. PMC: 8811537. DOI: 10.1016/j.jhep.2021.04.055. View